Nizoral is a Small Molecule owned by Johnson & Johnson, and is involved in 4 clinical trials, which were completed.
Ketoconazole is a synthetic derivative of phenylpiperazine with broad antifungal properties. Ketoconazole inhibits sterol 14-a-dimethylase, a microsomal cytochrome P450-dependent enzyme, thereby disrupting synthesis of ergosterol, an important component of the fungal cell wall.
The revenue for Nizoral is expected to reach a total of $847m through 2038. This change impacts the valuation of this asset and is an important factor to understand the current value of the drug in a clinical process. View the complete picture with the Nizoral NPV Report.
Ketoconazole (Nizoral, Nizoral GR, Nizral, Daktarin Gold, Terzolin, Ketoderm, Fungarest, Cetonax, Nizoral A-D, Triatop, Niz, Fungoral, Ketoconazole Patriot) is an anti fungal, anti infective agent. It is formulated as gel, solution, lotion, shampoo and cream for topical application and as tablets, granules and suspension for oral route of administration and ovule for vaginal route administration. Ketoconazole is indicated for the treatment of fungal infections, skin infections, dermatophytosis, onychomycosis (tinea unguium), pityriasis simplex capillitii (dandruff), folliculitis, vulvovaginal candidiasis, histoplasmosis, coccidioidomycosis, blastomycosis, cutaneous candidiasis,athlete''s foot (tinea pedis), tinea corporis, tinea cruris (jock itch), tinea capitis, seborrhea, dermatitis. Nizoral ovule is indicated for the treatment of acute and chronic vaginal candidiasis.
Alliance Pharma Overview
Alliance Pharma (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration, and marketing of pharmaceutical products. The company offers acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women’s health, infectious disease, respiratory, immunology, gastrointestinal, nutrition, toxicology and mouth and dental disorders. It distributes products through wholesalers, retail pharmacies, hospitals and international network of distributors. The company operates in the UK, Ireland, British Virgin Islands, France, the US, and Germany. Alliance is headquartered in Chippenham, Wiltshire, UK.
The company reported revenues of (British Pounds) GBP163.2 million for the fiscal year ended December 2021 (FY2021), an increase of 25.7% over FY2020. In FY2021, the company’s operating margin was 13.2%, compared to an operating margin of 12.6% in FY2020. In FY2021, the company recorded a net margin of 4.5%, compared to a net margin of 6.2% in FY2020.
Quick View – Nizoral
|Highest Development Stage|